Boston-Area Hospital Protocols
With National Institute of Health funding, Dr. David Christiani analyzes hereditary and environmental factors that may play a role in disease development and progression. His diseases of interest includelung cancer, esophageal cancer, and acute lung injury (ALI)/acute respiratory distress syndrome (ARDS), all of which affect thousands of families each year. In collaboration with the Harvard School of Public Health, Dr. Christiani conducts molecular and genetic analysis of these conditions at several Boston hospitals including Massachusetts General Hospital, Dana Farber Cancer Institute, and Beth Israel Deaconess Medical Center. Data collected from questionnaires and medical charts, along with lab work at the molecular level, may aid in disease prevention and development of new treatment for future generations.
These studies are done for research purposes, to generate scientific knowledge about the genetic basis of disease. This research is not intended to provide participants with specific information about their genetic status or health. No individual results will be given back to study participants. In addition, privacy will be preserved to the fullest extent by the research team. Any tissue samples (blood, cheek cell, or tumor) and personal medical information (gathered from questionnaires or the medical chart) are maintained in secure locations and coded to remain confidential. For more information on specific studies, please use the menu on the left.